PMC5989289_01
Cardiac magnetic resonance imaging 4-chamber-view post gadolinium injection revealing late gadolinium enhancement of the endomyocardium at the left ventricular apex.
CRIC2018-7017286.001.jpg
PMC5989289_01_CRIC2018-7017286.001.jpg
fig1
There was late gadolinium enhancement in the same area, consistent with oedema in the apical endomyocardium (Figure 1). There was also a nonenhancing mass in the left ventricular apex consistent with thrombus and small bilateral pleural effusions (Figure 2).
Cardiac magnetic resonance imaging 4-chamber view (still frame from a steady-state free precession (SSFP) cine sequence) with the left ventricular apical mass taken shortly after presentation.
CRIC2018-7017286.002.jpg
PMC5989289_01_CRIC2018-7017286.002.jpg
fig2
There was late gadolinium enhancement in the same area, consistent with oedema in the apical endomyocardium (Figure 1). There was also a nonenhancing mass in the left ventricular apex consistent with thrombus and small bilateral pleural effusions (Figure 2).
Cardiac magnetic resonance imaging 4-chamber view (still frame from a steady-state free precession (SSFP) cine sequence) taken 3 weeks after the previous study and on treatment (apixaban and antibiotics) demonstrating resolution of the apical mass.
CRIC2018-7017286.003.jpg
PMC5989289_01_CRIC2018-7017286.003.jpg
fig3
Tissue characterisation was consistent with apical wall oedema, which had reduced significantly in size since the previous CMR, and complete resolution of the left ventricular apical mural thrombus and pleural effusions (Figure 3).